Mydecine Innovations Group Inc.
MYCOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $240 | $606 | $5,035 | $651 |
| - Cash | $0 | $38 | $11 | $1,495 |
| + Debt | $6,875 | $5,423 | $4,782 | $4,502 |
| Enterprise Value | $7,115 | $5,991 | $9,806 | $3,658 |
| Revenue | $0 | $0 | $0 | $7 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$10 | -$129 | $7 |
| % Margin | – | – | – | 100% |
| EBITDA | -$2,475 | -$9,383 | -$15,709 | -$23,142 |
| % Margin | – | – | – | -308,854.5% |
| Net Income | -$3,152 | -$20,947 | -$11,849 | -$28,897 |
| % Margin | – | – | – | -385,658.6% |
| EPS Diluted | -0.053 | -0.68 | -1.37 | -6.17 |
| % Growth | 92.2% | 50.4% | 77.8% | – |
| Operating Cash Flow | -$37 | -$4,217 | -$8,428 | -$24,052 |
| Capital Expenditures | $0 | $0 | -$35 | -$404 |
| Free Cash Flow | -$37 | -$4,217 | -$8,463 | -$24,457 |